跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
LUMIFY
Authorized
STANDARD
LUMIFY
bausch & lomb inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
458a2531a09978a0
Company
bausch & lomb inc
Type
Standard
Approval Details
Approval Id
458a2531a09978a0
Drug Approval Canada Name
LUMIFY
Product Name
LUMIFY
Status
Marketed
Status Date
2022-07-05
Original Market Date
2022-07-05
Din
02517698
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
52:40.04
Atc Original
S01EA05 BRIMONIDINE
Atc Name
s 01 ea 05
Aig Number
0131859004
Company Name
bausch & lomb inc
Company Address
1400 N Goodman Street, Rochester, New York, United States, 14609
Active Ingredients
BRIMONIDINE TARTRATE
0.025 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
458a2531a09978a0
Type
Standard
Back to Health Canada Approvals